Showing promise in the landscape of weight management therapy, retatrutide is a different strategy. Unlike many available medications, retatrutide works as a twin agonist, simultaneously engaging both GLP-like peptide-1 (GLP-1) and glucose-responsive insulinotropic hormone (GIP) binding sites. The concurrent activation encourages several advantageo